News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
228,899 Results
Type
Article (9479)
Company Profile (18)
Press Release (219402)
Section
Business (68355)
Career Advice (133)
Deals (11927)
Drug Delivery (13)
Drug Development (31842)
Employer Resources (20)
FDA (5248)
Job Trends (4853)
News (115217)
Policy (7845)
Tag
2024 BioCapital Digital (1)
2024 BioMidwest Digital (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (1)
2024 Biotech Beach Standard (2)
2024 Genetown Standard (1)
Academia (736)
Adcomms (4)
Allergies (30)
Alliances (11877)
ALS (45)
Alzheimer's disease (631)
Antibody-drug conjugate (ADC) (55)
Approvals (5316)
Artificial intelligence (118)
Autoimmune disease (11)
Automation (7)
Bankruptcy (98)
Best Places to Work (4562)
BIOSECURE Act (5)
Biosimilars (37)
Biotechnology (18)
Bladder cancer (44)
Brain cancer (13)
Breast cancer (153)
Cancer (1168)
Cardiovascular disease (78)
Career advice (114)
Career pathing (4)
CAR-T (53)
Cell therapy (181)
Cervical cancer (12)
Clinical research (27215)
Collaboration (381)
Compensation (159)
Complete response letters (2)
COVID-19 (587)
CRISPR (10)
C-suite (93)
Cystic fibrosis (54)
Data (1171)
Denatured (2)
Depression (13)
Diabetes (85)
Diagnostics (2078)
Digital health (9)
Diversity (1)
Diversity, equity & inclusion (4)
Drug discovery (43)
Drug pricing (17)
Drug shortages (2)
Duchenne muscular dystrophy (42)
Earnings (36618)
Editorial (11)
Employer resources (17)
Events (49447)
Executive appointments (320)
FDA (5795)
Featured Employer (2)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (2)
Funding (478)
Gene editing (32)
Generative AI (6)
Gene therapy (112)
GLP-1 (211)
Government (1013)
Grass and pollen (2)
Guidances (24)
Healthcare (6071)
Huntington's disease (9)
IgA nephropathy (12)
Immunology and inflammation (51)
Indications (15)
Infectious disease (634)
Inflammatory bowel disease (63)
Inflation Reduction Act (6)
Influenza (12)
Intellectual property (40)
Interviews (18)
IPO (6796)
IRA (9)
Job creations (628)
Job search strategy (104)
Kidney cancer (3)
Labor market (5)
Layoffs (77)
Leadership (1)
Legal (1394)
Liver cancer (36)
Lung cancer (208)
Lymphoma (73)
Machine learning (1)
Management (7)
Manufacturing (88)
MASH (28)
Medical device (4422)
Medtech (4424)
Mergers & acquisitions (5408)
Metabolic disorders (227)
Multiple sclerosis (40)
NASH (14)
Neurodegenerative disease (40)
Neuropsychiatric disorders (8)
Neuroscience (875)
NextGen: Class of 2025 (2134)
Non-profit (1140)
Northern California (1286)
Now hiring (2)
Obesity (113)
Opinion (61)
Ovarian cancer (31)
Pain (34)
Pancreatic cancer (37)
Parkinson's disease (80)
Partnered (6)
Patents (68)
Patient recruitment (46)
Peanut (19)
People (16739)
Pharmaceutical (10)
Phase I (6871)
Phase II (11544)
Phase III (10641)
Pipeline (528)
Podcasts (12)
Policy (19)
Postmarket research (1191)
Preclinical (3038)
Press Release (15)
Prostate cancer (55)
Psychedelics (5)
Radiopharmaceuticals (88)
Rare diseases (161)
Real estate (1224)
Recruiting (8)
Regulatory (6183)
Reports (9)
Research institute (661)
Resumes & cover letters (22)
Rett syndrome (3)
RSV (12)
Schizophrenia (30)
Series A (104)
Series B (75)
Service/supplier (3)
Sickle cell disease (22)
Southern California (1126)
Special edition (3)
Spinal muscular atrophy (33)
Sponsored (7)
Startups (2389)
Stomach cancer (9)
Supply chain (26)
The Weekly (10)
United States (10353)
Vaccines (161)
Venture capitalists (35)
Webinars (5)
Weight loss (53)
Women's health (11)
Date
Today (53)
Last 7 days (342)
Last 30 days (1402)
Last 365 days (16052)
2025 (4388)
2024 (15360)
2023 (15539)
2022 (19865)
2021 (19920)
2020 (18886)
2019 (15720)
2018 (11951)
2017 (10962)
2016 (10125)
2015 (12449)
2014 (9166)
2013 (6850)
2012 (7504)
2011 (8151)
2010 (7513)
Location
Africa (136)
Alabama (18)
Alaska (2)
Arizona (57)
Arkansas (7)
Asia (12275)
Australia (1802)
California (2946)
Canada (973)
China (253)
Colorado (130)
Connecticut (168)
Delaware (90)
Europe (29497)
Florida (337)
Georgia (84)
Idaho (12)
Illinois (235)
India (14)
Indiana (130)
Iowa (4)
Japan (89)
Kansas (19)
Kentucky (6)
Louisiana (4)
Maine (28)
Maryland (344)
Massachusetts (2225)
Michigan (70)
Minnesota (148)
Missouri (53)
Montana (2)
Nebraska (2)
Nevada (18)
New Hampshire (18)
New Jersey (837)
New Mexico (10)
New York (777)
North Carolina (366)
North Dakota (2)
Northern California (1286)
Ohio (82)
Oklahoma (4)
Oregon (10)
Pennsylvania (505)
Puerto Rico (4)
Rhode Island (6)
South America (237)
South Carolina (3)
Southern California (1126)
Tennessee (50)
Texas (400)
Utah (80)
Virginia (57)
Washington D.C. (19)
Washington State (262)
West Virginia (1)
Wisconsin (37)
228,899 Results for "warburg pincus ventures l p".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mashura Announces $300M Strategic Partnership with Warburg Pincus
January 7, 2025
·
4 min read
Deals
Advent International and Warburg Pincus Complete Acquisition of Baxter’s BioPharma Solutions Business
Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor, announced the completion of their previously announced acquisition of Baxter International Inc.’s BioPharma Solutions business.
October 2, 2023
·
4 min read
BioMidwest
Baxter Signs Definitive Agreement to Divest its BioPharma Solutions Business to Advent International and Warburg Pincus for $4.25 Billion
Baxter International Inc., a leading global medtech company, announced that it has signed a definitive agreement to divest its BioPharma Solutions business to Advent International, one of the largest and most experienced global private equity investors, and Warburg Pincus, a leading global growth investor.
May 8, 2023
·
9 min read
Ono Expands Investment in Ono Venture Investment Fund I, L.P. to US$200 Million
Ono Pharmaceutical Co., Ltd. announced that in order to accelerate the open innovation, it has increased its investment pool from US$100 million to US$200 million to continue strategic investment in Ono Venture Investment Fund I, L.P., which was established as a corporate venture capital fund in CA, USA in May 2020.
December 1, 2023
·
1 min read
Press Releases
Frazier Life Sciences Appoints Biotech Innovators Mitchell H. Gold and Stanford L. Peng as Venture Partners
January 9, 2025
·
4 min read
J.P. Morgan Raises Over $500M for First Biotech Venture Capital Fund
J.P. Morgan’s life sciences venture capital arm on Thursday announced it closed its first biotech fund, targeting companies in cardiometabolic disease, immunology, oncology and genetic medicine.
June 14, 2024
·
2 min read
·
Tyler Patchen
Press Releases
SNBL and Tasso, Inc. to Establish Joint Venture in Japan
March 28, 2025
·
2 min read
Biotech Bay
Bioluminescence Ventures Emerges from Stealth with $477M AUM
Bioluminescence Ventures today announced its emergence from stealth with $477M in assets under management across two funds: Bioluminescence Ventures Fund I, L.P., and Bioluminescence Ventures Fund II, L.P.
November 1, 2023
·
5 min read
Press Releases
Qolab Secures Investment from Applied Ventures and Announces Collaboration to Advance Quantum Computing Manufacturing
March 17, 2025
·
2 min read
Deals
Quantum Health Announces Growth Investment from Warburg Pincus and Great Hill Partners
Warburg Pincus will partner with existing investor, Great Hill Partners, to accelerate Quantum Health’s strategic initiatives and growth opportunities
November 20, 2020
·
6 min read
1 of 22,890
Next
